Morphologic response to chemotherapy containing bevacizumab in patients with colorectal liver metastases: A post hoc analysis of the WJOG4407G phase III study

The phase III West Japan Oncology Group (WJOG) 4407G study showed noninferiority of folinic acid, bolus/continuous fluorouracil, and irinotecan plus bevacizumab to modified folinic acid, bolus/continuous fluorouracil, and oxaliplatin 6 plus bevacizumab in progression-free survival (PFS) as first-lin...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosokawa, Ayumu, Yamazaki, Kentaro, Matsuda, Chu, Ueda, Shinya, Kusaba, Hitoshi, Okamura, Shu, Tsuda, Masahiro, Tamura, Takao, Shinozaki, Katsunori, Tsushima, Takahiro, Tsuda, Takashi, Shirakawa, Tsuyoshi, Yamashita, Haruhiro, Morita, Satoshi, Hironaka, Shuichi, Muro, Kei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478588/
https://www.ncbi.nlm.nih.gov/pubmed/32899071
http://dx.doi.org/10.1097/MD.0000000000022060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478588/
https://www.ncbi.nlm.nih.gov/pubmed/32899071
http://dx.doi.org/10.1097/MD.0000000000022060

Ejemplares similares